Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

Pharmaceuticals

European Pharmaceuticals

  • Dechra Veterinary Products EU ("DVP EU")
    Sales, marketing and technical support of Dechra's branded veterinary products to the veterinary profession
    in Europe
  • Dechra Manufacturing
    Licensed manufacturer of veterinary and human pharmaceuticals for DVP EU and third party customers

Revenue

£ million

up 17.3%

Operating Profit

£ million

up 28.4%

US Pharmaceuticals

  • Dechra Veterinary Products US ("DVP US")
    Sales, marketing and technical support of Dechra's branded endocrine, ophthalmic, dermatological and equine products to the veterinary profession in the USA

Revenue

£ million

up 26.4%

Operating Profit

£ million

up 21.2%

Product Development

The Product Development and Regulatory Team develop and license Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets

Research and Development Spend

£ million

up 9.8%

Where we Operate

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.